Pharmaceutical investment decisions are becoming increasingly complex. Companies looking to expand manufacturing capacity are assessing more than market demand alone, with supply chain resilience, regional production, regulatory requirements, operating costs, and geopolitical considerations all influencing where new capital is directed.

Against this changing backdrop, Coherent Market Insights (CMI) is participating as the Strategic Partner for Pharmaconex 2026, bringing its market research capabilities to one of the industry's key meeting platforms.

Organized by Informa Egypt LLC, Pharmaconex 2026 will be held from September 1–3, 2026, at the Egypt International Exhibition Centre in Cairo. The exhibition is expected to connect pharmaceutical manufacturers, API producers, CDMOs, distributors, investors, and other stakeholders from across the global pharmaceutical value chain.

Identifying Emerging Investment Opportunities

As pharmaceutical companies reconsider their manufacturing and sourcing strategies, identifying the markets and segments attracting new investment has become increasingly important.

CMI will contribute its Executive Market Intelligence Report, “Global Pharmaceutical Manufacturing & API Market: Trends, Investment Outlook & Forecast 2026–2033.” The research explores the forces shaping pharmaceutical manufacturing and API markets, with a focus on production capacity, supply chain localization, regulatory developments, market dynamics, and investment trends.

The report is intended to provide stakeholders with a broader view of how the pharmaceutical manufacturing ecosystem could develop through 2033. By bringing together market data and industry analysis, it can support companies evaluating expansion plans, sourcing strategies, partnerships, and potential investment opportunities.

Bringing Research Closer to Decision-Makers

Pharmaconex 2026 offers an environment where industry professionals can exchange ideas, identify business opportunities, and explore developments across pharmaceutical manufacturing.

CMI's involvement adds a research-focused perspective to these conversations. Instead of relying solely on market sentiment, stakeholders can use structured market intelligence to better evaluate the trends influencing manufacturing and API supply chains.

The partnership also extends beyond the physical exhibition. CMI will leverage its B2B subscriber network and international digital and media outreach to distribute relevant insights to pharmaceutical professionals across multiple markets, including audiences who may not be present at the Cairo event.

Supporting Better-Informed Decisions

Commenting on the partnership, Raj Shah, CEO and Founder of Coherent Market Insights, said:

“Through our partnership with Pharmaconex 2026, CMI aims to provide stakeholders with actionable intelligence and strategic perspectives that support informed decision-making and sustainable growth.”

As pharmaceutical manufacturers and investors navigate an environment shaped by changing supply chains, evolving regulations, and new regional opportunities, reliable market intelligence can play an important role in evaluating the direction of future investment.

About Pharmaconex 2026

Pharmaconex 2026, organized by Informa Egypt LLC, is a leading pharmaceutical exhibition connecting manufacturers, API producers, suppliers, CDMOs, healthcare innovators, distributors, and investors.

The exhibition creates opportunities for professionals across the pharmaceutical value chain to explore technologies, develop business relationships, exchange industry knowledge, and identify opportunities across the MENA region and global markets.

About Coherent Market Insights

Coherent Market Insights (CMI) is a global market intelligence and consulting firm delivering data-driven research and strategic insights across multiple industries. Headquartered in India, CMI has a presence in the U.S. and strategic partnerships across the U.K. and Japan.

The company serves clients in 32+ countries, supported by 300+ full-time consultants and a global network of domain experts across 24 countries. CMI provides market research and consulting solutions designed to help organizations understand market trends, assess competitive environments, identify growth opportunities, and make informed strategic decisions.

For business inquiries: [email protected]